Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome
Sponsor: Stanford University
Summary
This single-center study aims to evaluate both immediate and long-term outcomes of stellate ganglion block (SGB) in a cohort of rigorously phenotyped patients with Postural Tachycardia Syndrome (POTS). By assessing the effects of SGB, this study seeks to determine its viability as an intervention for symptom control in POTS.
Official title: Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome: A Randomized Double Blind Sham Placebo-controlled Pilot Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-10-13
Completion Date
2026-11
Last Updated
2025-10-15
Healthy Volunteers
No
Conditions
Interventions
Stellate ganglion block
Patients will receive a SGB
Sham injection of saline
Patients will receive a subcutaneous sham injection of saline
Ropivacaine
The SGB group will receive ropivacaine 0.5% 10ml
Normal saline
The control group will receive normal saline in the sham injection.
Locations (2)
Stanford University School of Medicine
Stanford, California, United States
Stanford University
Stanford, California, United States